01—Abstract
Summary
Summary of the 8-K filed July 31, 2025. Cited figures are marked; the original filing is the authoritative source.
On July 31, 2025, UnitedHealth Group (UNH) announced a leadership change in its finance function.
Wayne S. DeVeydt, a former Elevance Health (formerly Anthem) CFO and current Bain Capital managing director, will become Chief Financial Officer effective September 2, 2025. John F.
Rex, CFO since 2016, will transition to a Strategic Advisor role to CEO and Chairman Stephen J. Hemsley on the same date, under a 2016 employment contract. The filing's most investor-relevant content is DeVeydt's compensation package.
It includes a $1,000,000a base salary, a 200% initial target bonus, a $10 million annual stock award target (pro-rated to $3 million for 2025), a $1.2 million cash sign-on bonus subject to clawback, and a $5 million sign-on stock award. Severance equals two times base salary plus the last two years' bonuses on termination without cause or for good reason. The filing does not disclose a reason for Rex's departure from the CFO role.
For investors, the change is a planned transition with an overlap-free handoff date and an experienced health-insurance finance executive joining. DeVeydt's background at Anthem/Elevance, where he served as CFO for nine years, is directly relevant to managed care economics. The filing is a routine executive appointment disclosure and contains no reported financial results or guidance changes.
02—Key points
Key Highlights
- Wayne S. DeVeydt appointed CFO effective September 2, 2025, succeeding John F. Rex, who has served as CFO since 2016
- Rex transitions to Strategic Advisor to the CEO on the same date under a 2016 employment contract
- DeVeydt's background includes nine years as CFO of Elevance Health (Anthem), giving direct managed-care finance experience
- Base salary of $1,000,000 with a 200% initial target annual bonus
- Annual stock award target of $10 million (pro-rated to $3 million for 2025), plus a $5 million sign-on stock award
- $1.2 million sign-on cash bonus replacing forgone compensation, subject to clawback for termination for cause or resignation without good reason
- Severance of two times base salary plus the last two years' bonuses on termination without cause or for good reason
03—Questions
Frequently Asked Questions
Who is the new CFO of UnitedHealth Group and when does the change take effect?
Wayne S. DeVeydt, age 55, becomes CFO effective September 2, 2025. He most recently was a managing director at Bain Capital and previously was CFO of Elevance Health (formerly Anthem) from 2007 to 2016.
What happens to outgoing CFO John Rex?
John F. Rex, CFO since 2016 and with the company since 2012, becomes a Strategic Advisor to CEO Stephen J. Hemsley on September 2, 2025, in accordance with his 2016 employment contract. The filing does not state a reason for the transition.
What is DeVeydt's compensation package?
He receives a $1 million base salary, a 200% initial target bonus, and an annual stock award target of $10 million, pro-rated to $3 million for 2025. He also receives a $1.2 million cash sign-on bonus and a $5 million sign-on stock award split between RSUs and NSOs. For 2026 he is expected to receive a PSU award comprising a majority of the stock award value, subject to Compensation Committee approval.
Are there protections or clawbacks in the agreement?
The $1.2 million sign-on bonus is subject to clawback if DeVeydt is terminated for cause or resigns without good reason, as defined in the 2025 proxy statement. Equity awards vest subject to restrictive covenants. Severance is two times base salary plus the last two years' bonuses if he is terminated without cause or resigns for good reason.
Does this announcement change UnitedHealth's financial outlook?
The filing contains no financial results, guidance, or outlook changes. It is a leadership and compensation disclosure only, so investors should look to the company's earnings releases and guidance for any changes to financial expectations.
04—Continue